Allgens(SH:688613) Xin Lang Cai Jing·2025-09-28 07:41Core Viewpoint - The company, AoJing Medical (688613.SH), has received approval from the National Medical Products Administration for its absorbable composite bone repair material, enhancing its product portfolio in the bone repair materials sector [1] Product Development - The approved product incorporates absorbable polyester materials, improving strength and controllable degradation, which better addresses various clinical conditions for bone defect repair [1] - The product is developed independently by the company and possesses complete intellectual property rights, achieving an internationally leading technological level [1] Market Impact - The registration certificate for the new product enhances the company's product layout in the bone repair materials field, facilitating overall market expansion domestically [1] - Actual sales performance will depend on the product's competitiveness and market sales capabilities, with no current predictions available regarding its impact on the company's future operating performance [1]